NextCure  Inc (NXTC) Stock Analysis

NextCure  Inc (NXTC) is a publicly traded company in the HEALTHCARE sector. It trades at $3.40, carries a market capitalization of $12.21M. This page summarizes the public market data, fundamentals, and frequently asked questions for NXTC, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $3.40
• Market Cap: $12.21M
• EPS: $-16.82
• 52-Week High: $15.74
• 52-Week Low: $2.85

Market Sentiment

NextCure  Inc currently has a Bullish sentiment score of 0.39.

About NextCure  Inc

NextCure, Inc. (NXTC) is a clinical-stage biopharmaceutical firm located in Beltsville, Maryland, dedicated to pioneering immunomedicines for cancer and various immune-related disorders. Utilizing its advanced NEX-T technology platform, the company aims to restore and optimize immune function, thereby developing innovative treatment options for patients with significant therapeutic gaps. With a robust pipeline and a commitment to addressing pressing healthcare challenges, NextCure is strategi...

GNG Research Analysis

GNG Research scores NextCure  Inc (NXTC) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for NXTC.

Frequently Asked Questions

Does NXTC pay dividends?

NextCure  Inc (NXTC) does not currently pay a regular dividend.

What is NXTC's market cap?

NextCure  Inc (NXTC) has a market capitalization of $12.21M with a current stock price of $3.40.